GE HealthCare Technologies Inc. (GEHC)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | ||
|---|---|---|---|---|
| Net income | US$ in thousands | 1,993,000 | 1,568,000 | 1,916,000 |
| Total stockholders’ equity | US$ in thousands | 8,446,000 | 7,133,000 | 9,357,000 |
| ROE | 23.60% | 21.98% | 20.48% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $1,993,000K ÷ $8,446,000K
= 23.60%
Based on the provided information, GE HealthCare Technologies Inc.'s return on equity (ROE) has shown a positive trend over the past three years.
As of December 31, 2022, the company's ROE stood at 20.48%, indicating that for every dollar of shareholders' equity, the company generated a return of 20.48%. This was followed by an increase in ROE to 21.98% as of December 31, 2023, showing improved profitability and efficiency in utilizing the shareholders' equity.
The most recent data as of December 31, 2024, reveals a further increase in ROE to 23.60%. This upward trend in ROE suggests that the company has been effectively leveraging its equity to generate profits for its shareholders.
Overall, the progressive improvement in GE HealthCare Technologies Inc.'s return on equity indicates that the company is efficiently using its resources to generate earnings and create value for its shareholders.
Peer comparison
Dec 31, 2024